This strategy is part of a growing trend in immunotherapy that focuses not just on guiding immune responses, but on upgrading the cells themselves — enhancing their efficiency from within.

The brothers of 23-year-old Paloma Shemirani who died because she refused chemotherapy said their sister died because of ...